Showing results (161-170 of 251) with videos related to
Sort By:
Pageof 26
Alimentary Pharmacology & Therapeutics|October 4, 2019
Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitisMaia Kayal, Michael Plietz, Marlana Radcliffe, et al.Inflammatory Bowel Diseases|February 20, 2007
IL-23 receptor (IL-23R) gene protects against pediatric Crohn's diseaseMarla C Dubinsky, Dai Wang, Yoana Picornell, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.The American Journal of Gastroenterology|March 17, 2025
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND StudiesJoana Torres, Julian Panés, Corey A Siegel, et al.Journal of Clinical Gastroenterology|June 11, 2021
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBDEdward L Barnes, John S Hanson, Miguel D Regueiro, et al.International Journal of Colorectal Disease|September 13, 2019
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample studyMaia Kayal, Aparna Saha, Priti Poojary, et al.Journal of Crohn'S & Colitis|July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical ProgrammeStefan Schreiber, David T Rubin, Siew C Ng, et al.The American Journal of Gastroenterology|August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel DiseaseAdam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.Journal of Patient-Reported Outcomes|July 1, 2025
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumabDavid B Clemow, Marla C Dubinsky, Simin K Baygani, et al.Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.Pageof 26